SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-12-001440
Filing Date
2012-01-10
Accepted
2012-01-09 20:27:20
Documents
1
Group Members
MICHAEL S. WEISS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D v245087_sc13d.htm SC 13D 87637
  Complete submission text file 0001144204-12-001440.txt   89395
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Subject) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-51051 | Film No.: 12518575
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 7TH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address 787 7TH AVENUE 48TH FLOOR NEW YORK NY 10019 212-554-4504
Opus Point Partners, LLC (Filed by) CIK: 0001503454 (see all company filings)

IRS No.: 262737756 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D